The BJC provides a forum for clinicians and scientists to communicate original research findings that have relevance to understanding the etiologyofcancer and to improving patient treatment and survival. Once accepted, papers are published in print and online.
Full research papers are published under six broad headings:
The journal was founded in 1947 by the then British Empire Cancer Campaign (later named Cancer Research Campaign),[1] one of the research charities which later merged to form Cancer Research UK. Cancer Research Campaign began partnering with Nature as publisher of the journal in the 1980s, but retained ownership and editorial control. In 2021, after the charity experienced a fall in charitable income during the COVID-19 pandemic, Cancer Research UK sold the journal to Springer Nature.[2]
According to the Journal Citation Reports, the journal received an impact factor of 9.0,[3] ranking it 39th journals in the category of Oncology.[4]SJR ranked BJC as 30th journal in cancer research with H-index 224.[5]
BJC is a top cited general cancer journal committed to publishing cutting edge discovery, translational and clinical cancer research.[6] The journal is indexed in:
)
